Sarah Cannon Research Institute, LLC — Nashville, Tennessee

Sarah Cannon Research Institute, LLC is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute, LLC has participated in 9 clinical trials with 4 currently active.

Therapeutic areas: Metastatic Castrate Resistant Prostate Cancer (mCRPC), Advanced Solid Tumors, Gastric Cancer.

Sponsors: Pfizer, Five Prime Therapeutics, Inc., CytomX Therapeutics.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute, LLC?

Sarah Cannon Research Institute, LLC has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute, LLC conducted?

Sarah Cannon Research Institute, LLC has 9 clinical trials on record, with 4 currently active. Their work covers Metastatic Castrate Resistant Prostate Cancer (mCRPC), Advanced Solid Tumors, Gastric Cancer.

Is Sarah Cannon Research Institute, LLC accredited by Crixeo Health?

Yes — Sarah Cannon Research Institute, LLC holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Sarah Cannon Research Institute, LLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.